What is the arrhythmic substrate in viral myocarditis? Insights from clinical and animal studies by Lai, ET et al.
Title What is the arrhythmic substrate in viral myocarditis? Insightsfrom clinical and animal studies
Author(s) Tse, G; Lai, ET; Chan, YW; Yeo, JM; Yan, BP
Citation Frontiers in Physiology, v. 7, p. article no. 308
Issued Date 2016
URL http://hdl.handle.net/10722/227132
Rights This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
REVIEW
published: 21 July 2016
doi: 10.3389/fphys.2016.00308
Frontiers in Physiology | www.frontiersin.org 1 July 2016 | Volume 7 | Article 308
Edited by:
Gaetano Santulli,
Columbia University, USA
Reviewed by:
Richard David Walton,
Université Bordeaux Segalen, France
Bozena Werner,
Medical University of Warsaw, Poland
*Correspondence:
Gary Tse
gary.tse@doctors.org.uk
Bryan P. Yan
bryan.yan@cuhk.edu.hk
Specialty section:
This article was submitted to
Cardiac Electrophysiology,
a section of the journal
Frontiers in Physiology
Received: 07 June 2016
Accepted: 06 July 2016
Published: 21 July 2016
Citation:
Tse G, Yeo JM, Chan YW, Lai ETH and
Yan BP (2016) What Is the Arrhythmic
Substrate in Viral Myocarditis?
Insights from Clinical and Animal
Studies. Front. Physiol. 7:308.
doi: 10.3389/fphys.2016.00308
What Is the Arrhythmic Substrate in
Viral Myocarditis? Insights from
Clinical and Animal Studies
Gary Tse 1, 2*, Jie M. Yeo 3, Yin Wah Chan 4, Eric T. H. Lai 1 and Bryan P. Yan 2, 5*
1 Li Ka Shing Faculty of Medicine, School of Biomedical Sciences, University of Hong Kong, Hong Kong, China, 2Department
of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China, 3 Faculty of Medicine, Imperial
College London, London, UK, 4Department of Psychology, School of Biological Sciences, University of Cambridge,
Cambridge, UK, 5Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Sudden cardiac death (SCD) remains an unsolved problem in the twenty-first century.
It is often due to rapid onset, ventricular arrhythmias caused by a number of different
clinical conditions. A proportion of SCD patients have identifiable diseases such as
cardiomyopathies, but for others, the causes are unknown. Viral myocarditis is becoming
increasingly recognized as a contributor to unexplained mortality, and is thought to be a
major cause of SCD in the first two decades of life. Myocardial inflammation, ion channel
dysfunction, electrophysiological, and structural remodeling may play important roles in
generating life-threatening arrhythmias. The aim of this review article is to examine the
electrophysiology of action potential conduction and repolarization and the mechanisms
by which their derangements lead to triggered and reentrant arrhythmogenesis. By
synthesizing experimental evidence from pre-clinical and clinical studies, a framework
of how host (inflammation), and viral (altered cellular signaling) factors can induce ion
electrophysiological and structural remodeling is illustrated. Current pharmacological
options are mainly supportive, which may be accompanied by mechanical circulatory
support. Heart transplantation is the only curative option in the worst case scenario.
Future strategies for the management of viral myocarditis are discussed.
Keywords: viral myocarditis, cardiac arrhythmia, mouse model, viral-induced cardiomyopathy, conduction,
repolarization
INTRODUCTION
Viral myocarditis is myocardial inflammation due to a viral infection. It is thought to be
a major cause of sudden cardiac death (SCD) in the pediatric and adolescent population
(Steinberger et al., 1996). Indeed, one study found that infants who suffered from SCD had
mild fever and insomnia several days prior to their deaths, suggesting infection as a major
contributor in this group (Gaaloul et al., 2016). At least 20 viruses have been implicated in
myocarditis, but the commonest virus involved are Parvovirus B19 (PVB19), human herpes
virus 6, adenovirus and coxsackievirus B3 (CVB3; Gaaloul et al., 2012). Table 1 summarizes the
known virus strains, gene/protein targets, and estimated prevalence. Not all viral infections are
the same: cardiotropic viruses are known to infect >90% of the human population, yet only
1–5% of these will develop viral myocarditis as proven histologically (Andreoletti et al., 2009).
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TABLE 1 | The prevalence of different viruses was obtained from Kühl et al. (2005) and Andreoletti et al. (2009).
Virus Type Host target Estimated prevalence References
Adenovirus dsDNA Common Coxsackievirus
B-adenovirus receptor
8–23% Bergelson et al., 1997; Bowles et al.,
2003; Kühl et al., 2005; Andreoletti et al.,
2009
Coxsackievirus ssRNA CD55, Common Coxsackievirus
B-adenovirus receptor
2 to 50% (Up to 46% after
transplantation)
Arbustini et al., 1992; Bergelson et al.,
1997; Martino et al., 1998; Bowles et al.,
2003; Andreoletti et al., 2009
Cytomegalovirus dsDNA Heparan Sulfate Proteoglycans,
PDGFRα, EGFR, and integrin
heterodimers
0.8–3% Bowles et al., 2003; Chan et al., 2012
Echovirus ssRNA Human very late antigen 2 (VLA-2) 10.5% Hughes et al., 2003; Kühl et al., 2005
Enterovirus ssRNA Enteroviral protease 2A directly
cleaves dystrophin
8–32.6% Badorff et al., 1999; Bowles et al., 2003;
Kühl et al., 2005
Epstein-Barr virus dsDNA Increased latent membrane protein 1
is expressed in EBV latent cells
0–6% Karjalainen et al., 1983; Bowles et al.,
2003; Chimenti et al., 2004
Hepatitis B virus dsDNA Enters injured endothelium <1% Reis et al., 2007; Rong et al., 2007
Hepatitis C virus ssRNA CD68 (monocytes and macrophages) 2.9–3.8% Matsumori et al., 2000; Reis et al., 2007;
Matsumori, 2012
Herpes simplex
virus
dsDNA <1% Bowles et al., 2003
Human herpes
virus 6
dsDNA ?NK cells; infects endothelium 8–10.5% Yoshikawa et al., 2001; Caruso et al.,
2002; Kühl et al., 2005; Andreoletti et al.,
2009
Human
immunodeficiency
virus 1 and 2
ssRNA Gp120 Common in HIV positive patients Shaboodien et al., 2013
Influenza virus ssRNA Ectopic trypsins 1.7–10% (up to 10% patients in
influenza pandemics)
Bowles et al., 2003; Rezkalla and Kloner,
2010; Pan et al., 2011; Ukimura et al.,
2012
Mumps virus ssRNA Up to 15% of mumps cases before
introduction of vaccine (associated
with endocardial fibroelastosis)
Rosenberg, 1945; Arita et al., 1981
Parvovirus B19 ssDNA B19 receptor (erythrocyte P antigen) 1–36.6% Porter et al., 1988; Bowles et al., 2003;
Kühl et al., 2005; Andreoletti et al., 2009
Polio virus ssRNA Up to 40% of cases of poliomyelitis Laake, 1951
Rabies virus ssRNA Invasion of neural tissue or blood cells ? Ross and Armentrout, 1962; Cheetham
et al., 1970; Venkat Raman et al., 1988;
Liao et al., 2012
Respiratory
syncytial virus
ssRNA ? <1% Huang et al., 1998; Bowles et al., 2003;
Eisenhut, 2006
Rubella virus ssRNA ? ? Ainger et al., 1966; Kriseman, 1984
Vaccinia virus
(smallpox vaccine)
dsDNA ? <1–9.5% Karjalainen et al., 1983; Casey et al.,
2005
Varicella virus dsDNA ? ? Woolf et al., 1987; Rich and McErlean,
1993; Alter et al., 2001; Biocic et al.,
2009; De et al., 2011
? - Information not available.
Patients can take a varied clinical course, from acute to
chronic inflammation involving focal or diffuse areas of the
myocardium (Fung et al., 2016). Figure 1 illustrates demonstrates
the histology from a case of viral myocarditis due to PVB19,
characterized by diffuse interstitial myocardial inflammatory
infiltrate composed of CD68 positive macrophages, CD3
lymphocytes in an interstitial and perivascular distribution with
minimal necrosis (Tavora et al., 2008). Some have insidious onset
with limited inflammation, others undergo fulminant course with
overwhelming inflammation or develop chronic heart failure
from an autoimmune-mediated process (Heymans, 2006). There
are some genetic predispositions, making some individuals more
susceptible to viral myocarditis. For example, the commonest
polymorphism for the KCNQ1 gene encoding for the slow
inactivating K+ channel in Asians, appears to be protective
against viral-induced arrhythmias (Steinke et al., 2013). Not
all viruses are the same: some viruses such as CVB3 and
adenovirus serotype 5 can induce more severe viral myocarditis
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FIGURE 1 | Histopathological findings in parvoviral myocarditis. (A) Diffuse interstitial myocardial inflammatory infiltrate more prominent around interstitial
capillaries and composed of macrophages and lymphocytes (20×). (B) Hematoxilin-eosin stain showing vasocentric inflammation (40×). (C,D) CD68 positive
macrophages were the most abundant cells present. (C-10X D-20X; E) Rare CD3 positive lymphocytes. (F) Essentially negative CD20 immunohistochemical stain.
Figure and figure legends reproduced from Tavora et al. (2008) with permission.
(Savon et al., 2008; Valdes et al., 2008). For the post-mortem
of infants suffering from SCD, only a minority of cases showed
features of myocardial inflammation (Gaaloul et al., 2012),
suggesting contributing factors, such as signals initiated by the
viruses leading to ion channel dysfunction or electrophysiological
and structural remodeling, to arrhythmogenesis. Fundamentally,
viruses must have somemeans of subverting the host’s machinery
for their replication to ensure their own survival. This can
be achieved by using the host’s signaling mechanisms or the
mircroRNA (miRNA) system to target the host’s messenger
RNAs for translational repression and degradation (Tomari
and Zamore, 2005). The aim is to shut down the host’s
protein translation machinery and enhance viral pathogenicity
or replication (Orom et al., 2008; Hemida et al., 2013; Tong
et al., 2013; Ye et al., 2013). As we shall see later, altered
cellular signaling, such as activation of kinases and enzymes, and
upregulation of miRNAs, can lead to ion channel remodeling
that can potentially reduce the threshold for arrhythmogenesis.
Thus, the host’s immune response or viral factor can induce
electrophysiological or structural remodeling, resulting in action
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potential (AP) conduction or repolarization abnormalities to
promote arrhythmogenesis (Figure 2; Tse and Yeo, 2015).
ARRHYTHMOGENESIS CAN ARISE FROM
AP CONDUCTION OR REPOLARIZATION
ABNORMALITIES
Mechanisms of arrhythmias can be divided into triggered activity
and reentry (Figure 3; Tse, 2015; Tse et al., 2016m). Triggered
activity arises from either early or delayed afterdepolarization
phenomena (EADs and DADs), which are depolarization events
occurring before the next AP. Normally the repolarization phase
is determined by a balance of inward currents mediated by the
Na+-Ca2+ exchanger (INCX) and L-type Ca
2+ channels (LTCC,
ICa,L), and outward currents mediated by a number of K
+
channels (IKr, IKs, IK1,IK,ATP; Nerbonne, 2000; Tse et al., 2016j).
Prolongation in action potential duration (APD) can result in
LTCC reactivation, typically during phase 2 or phase 3 of the AP,
leading to EADs (January et al., 1988). By contrast, DADs can
develop under conditions of intracellular Ca2+ overload (Priori
and Corr, 1990). This involves spontaneous release of Ca2+
from the sarcoplasmic reticulum via the ryanodine receptors
(RyRs) and subsequent activation of the Na+-Ca2+ exchanger
(NCX). Both EADs and DADs can therefore result in membrane
depolarization, and if these are of sufficient amplitude, triggered
activity can be elicited.
Reentry involves re-activation of the myocardium that has
recovered from refractoriness, and may involve an obstacle for
the circus-type, or without an obstacle in phase 2 reentry (Tse
et al., 2016d). Circus-type reentry requires three conditions:
reduced conduction velocity (CV) of the AP wave, so that
the tissue ahead remains excitable, unidirectional conduction
block to prevent APs traveling in opposite directions from
extinguishing, and an obstacle (which can arise dynamically
or be a fixed structural defect) around which the AP is able
to circulate (Tse, 2015). Thus, a decrease in the wavelength of
excitation (λ) given by the product of CV and reduced effective
refractory period (ERP), would predispose to reentry (Smeets
et al., 1986; Vaidya et al., 1999; Osadchii, 2010, 2014; Tse et al.,
2012, 2016e,f,g,k,o).
Of these parameters, CV of the APs traveling through the
myocardium, traditionally described by the core conductor
theory, depends on both passive and active membrane properties
(Tse and Yeo, 2015; Tse et al., 2016d). Passive properties
refer to the biophysical parameters of axial resistance (ri),
extracellular resistance (ro) and membrane capacitance (cm).
The existence of electrical communication pathways between
successive cardiomyocytes was shown, mediated by gap junctions
(Spray and Burt, 1990). Six connexin (Cx) subunits make up
a connexon and two connexons make up a gap junction.
Since the discovery of gap junctions, it has been assumed that
their electrical coupling is the primary mechanism by which
cardiac conduction occurs. However, this is in conflict with
experiments in heterozygous Cx43+/−− mice, which showed 45–
50% reduction in Cx43 expression, but CV was either unaltered
(Morley et al., 1999; Vaidya et al., 2001; van Rijen et al., 2004;
Stein et al., 2009, 2011; George et al., 2015) or reduced by 23–
44% (Guerrero et al., 1997; Thomas et al., 1998; Eloff et al., 2001).
This suggests other mechanisms, such as ephaptic coupling, may
have an important role in mediating cardiac conduction (Rhett
and Gourdie, 2012; Lin and Keener, 2013, 2014; Rhett et al.,
2013; Veeraraghavan et al., 2014a,b,c, 2015; George et al., 2015).
This is clinically relevant because interstitial edema can increase
FIGURE 2 | Host and viral factors can induce structural and electrophysiological remodeling to induce cardiac arrhythmogenesis. These include ion
channelopathies, oxidative stress, inflammation, and altered intracellular signaling. Together, these act to alter intercellular coupling, produce interstitial oedema and
fibrosis, which would lead to conduction abnormalities. Abnormal Ca2+ handling and K+ channel downregulation lead to abnormal repolarization.
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FIGURE 3 | Mechanisms of cardiac arrhythmias in viral myocarditis
involves triggered activity and reentry. Prolonged repolarization leads to
development of early afterdepolarizations (EADs), whereas abnormal Ca2+
handling produces delayed afterdepolarizations (DADs). EADs and DADs can
elicit triggered activity. Reduced conduction velocity (CV), increased CV
dispersion and decreased refractoriness can increase the likelihood of
circus-type reentry. Prolonged repolarization and decreased refractoriness can
predispose to phase 2 reentry.
extracellular volume, thereby reducing CV (Veeraraghavan et al.,
2012).
Active properties refer to the voltage-gated conductance
responsible for the AP upstroke, namely the Na+ channels.
The effective refractory period (ERP) is the time over which
Na+ channels are inactivated and cannot open again. They
can be reactivated when the membrane potential is restored to
the resting value. Thus, APD usually approximates ERP, i.e., a
shorter repolarization time course usually leads to shorter ERP.
When APDs are prolonged, sudden increase in heart rate can
engage the steep portion of APD restitution curve, producing
APD alternans, unidirectional conduction block, wave break and
reentry (Hsieh et al., 2009, 2014, 2016; Tse et al., 2016m). Phase
2 reentry simply involves a difference in APD between two
electrically connected regions, where conduction of the action
potential dome from sites where it is maintained to sites where
it is abolished can then result in an extrasystole (Shimizu et al.,
2005). This is thought to underlie reentrant arrhythmogenesis
in Brugada syndrome, and may be relevant in patients suffering
from viral myocarditis with an unmasked Brugada phenotype.
HOST-MEDIATED AND VIRAL-INDUCED
INFLAMMATION AND CAN PROMOTE
ARRHYTHMOGENESIS BY INDUCING ION
CHANNEL ABNORMALITIES AND
CARDIAC REMODELING
All of the above factors governing conduction or repolarization
can be affected by myocardial inflammation or changes induced
by the viruses to promote arrhythmogenesis. Thus, in a rat model
of immune-mediated myocarditis, increased oxidative stress and
inflammation can increase the release of inflammatory cytokines
such as tumor necrosis factor-α and interleukin-6, leading
to Ca2+/calmodulin Protein Kinase II (CaMKII) activation.
This can phosphorylate the Ca2+ release channel, ryanodine
receptor 2 (RyR2), to increase abnormal Ca2+ release from
the sarcoplasmic reticulum (Tse et al., 2016n). Moreover, there
is greater Ca2+ entry from the extracellular space (Tominaga
et al., 1993). Both would lead to increased duration of Ca2+
transient, which would in turn prolong APD due to positive
Ca2+i -APD coupling (Park et al., 2014a,b). This led to triggered
activity, presumably via development of EADs, although DADs
are also possible due to abnormal Ca2+ release. Regional
differences in Ca2+ transients can also increase the heterogeneity
in repolarization and produce arrhythmogenic APD alternans.
In a rat model of autoimmune myocarditis, several ion channels
mediating the fast transient outward (Ito,f) and delayed rectifier
(IKr) currents were downregulated (Saito et al., 2002; Wakisaka
et al., 2004). This led to prolongations of both ERP and APD, the
latter being responsible for EADs and triggered activity. Similar
reduction of repolarizing currents leading to APD prolongation
has also been observed in mice with autoimmune myocarditis
(Tang et al., 2007). Inflammation can also promote changes in the
extracellular matrix (ECM). Thus, ECM composition is regulated
by matrix metalloproteinases (MMPs), which are normally
inhibited by tissue inhibitors of matrix metalloproteinases
(TIMPs; Pauschinger et al., 2004). MMP activation during acute
myocarditis can tip the balance toward ECM remodeling, in
turn causing fibrosis. This would reduce CV by disrupting
cardiomyocyte-cardiomyocyte coupling or increasing fibroblast-
cardiomyocyte coupling, increasing ri and Cm, respectively (Tse
and Yeo, 2015). Moreover, viral myocarditis predisposes to the
development of dilated cardiomyopathy (DCM), which itself is
arrhythmogenic. Interested readers are directed to this excellent
article here for further discussion on the mechanisms by which
myocardial infections by cardiotropic viruses lead to DCM and
heart failure (Baksi et al., 2015).
Viruses can also alter the function or expression of ion
channels or induce structural remodeling of the myocardium.
CVB3 can increase the ICa, leading to APD prolongation
(Steinke et al., 2013). It also increases IKr and IKs initially but
decreases them in the longer term, leading to APD shortening
and prolongation, respectively. CVB3 can upregulate miR-1,
which in turn disrupts cardiomyocyte-cardiomyocyte coupling
by translational repression of the gene GJA1, which encodes for
connexin-43 (Cx43; Xu et al., 2012). Together, these changes
induced by CVB3 would produce Ca2+ overload and induce
abnormalities in action potential repolarization and conduction,
predisposing to both triggered activity and reentry. The
cardiotropic PVB19 appears to target endothelial cells as opposed
to cardiomyocytes (Bultmann et al., 2003). Since endothelial
cells are found in the heart and can communicate with the
adjacent cardiomyocytes, endothelial dysfunction may indeed be
responsible for cardiac remodeling during inflammation. PVB19
a pro-apoptotic protein called viral protein NS1, which can
activate caspase 3, leading to the degradation of the Na+/H+
exchanger (Lupescu et al., 2009). Its B19 minor capsid protein
VP1 has intrinsic phospholipase A2 activity, which can increase
the activity of Ca2+ release-activated Ca2+ channel (ICRAC),
which is normally responsible for capacitative, store-operated
Ca2+ entry by increasing ICa (Lupescu et al., 2006). PLA2 activity
of VP1 is thought to underlie downregulation of Na+/K+-
ATPase and a number of K+ channels (mediating IKr and inward
rectifying currents, IKir; Almilaji et al., 2013; Ahmed et al., 2014,
2015).
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Finally, there may be interaction between genetic
predisposition of ion channel dysfunction and viral myocarditis
(Salerno et al., 2011; Juhasz et al., 2014). In a case series, patients
who suffered from viral myocarditis complicated by ventricular
fibrillation showed electrocardiographic features of Brugada,
early repolarization and short QT syndromes (Salerno et al.,
2011). Interestingly, not only were ventricular arrhythmias
observed during the acute phase of the myocarditis but persistent
ECG changes were observed after the inflammation has subsided,
suggesting underlying abnormalities in ion channel function,
predisposing to arrhythmogenesis during myocarditis. Indeed,
as pointed out by these authors (Salerno et al., 2011), this could
be due to temperature-dependent alterations in ion channel
function (Pasquié, 2005). This notion is consistent with previous
observations that infants suffering from SCD had mild fever
before their deaths (Gaaloul et al., 2016), which would suggest
fever as a trigger of the arrhythmia (Pasquié, 2005). This is also
in keeping with previous associations between exacerbation of
a Brugada pattern and a febrile state (Patane and Marte, 2010;
Patane et al., 2010).
CURRENT MANAGEMENT OPTIONS AND
FUTURE THERAPY
Diagnosis of viral myocarditis can be difficult, and requires
a series of investigations. Blood tests may reveal cardiac
damage as reflected in raised troponins and high sensitive C-
reactive protein assays (Guo, 2008). Polymerase chain reaction
(PCR) can be used to detect viral nucleic acid materials for
confirming a specific viral infection. Electrocardiography is
non-specific, but can reveal conduction block, ST segment
elevation or T wave abnormalities. Ventricular tachycardia
or fibrillation may be observed. Echocardiography is used to
determine ventricular function and rule out non-viral causes
of heart failure, and can distinguish between acute from
fulminant myocarditis (Felker et al., 2000). Cardiac magnetic
resonance imaging is excellent for characterizing structural
abnormalities, such as areas of fibrosis by late gadolinium
enhancement (Vassiliou et al., 2014; Tse et al., 2015a,b) It
is highly valuable in the diagnosis of myocarditis because it
can detect interstitial edema during acute inflammation and
fibrosis from a reparative process (Babu-Narayan et al., 2007;
Petryka et al., 2014; Baksi et al., 2015). Interstitial edema reflects
increased extracellular fluid volume, which would reduce CV
by an ephaptic mechanism. Traditionally, the confirmatory test
for diagnosing viral myocarditis was endomyocardial biopsy,
which can be guided by electro-anatomical mapping to reduce
the likelihood of false negatives. The criteria is a value more
than 14 leukocytes/mm2 and a T-lymphocyte count of more than
7 cells/mm2 (Basso et al., 2013). However, due to advances in
CMR technology, the use of biopsy is now limited when giant
cell myocarditis is suspected.
For arrhythmic risk stratification, using different indices based
on ECG parameters have been used for congenital arrhythmic
syndromes and heart failure (Tse, 2016a,b,c; Tse and Yan,
2016a,b), but not for viral myocarditis. CMR can be used for
stratifying patients into low and high risk group for developing
ventricular arrhythmogenesis by quantifying the amount of
interstitial edema and fibrosis, which would guide monitoring
and therapy (Strauss andWu, 2009; Mavrogeni et al., 2013; Baksi
et al., 2015; Kallianos et al., 2015; Neilan et al., 2015; Sanguineti
et al., 2015; Anzini et al., 2016).
The major problem of viral myocarditis is the limited number
of drugs available for modifying the course of the disease and
preventing the arrhythmic complications (Kindermann et al.,
2012). The current treatment is supportive, using medications
such as angiotensin converting enzyme inhibitors, beta blockers
and spironolactone. Anti-arrhythmic agents are used when
ventricular arrhythmias are observed. Mechanical circulatory
support is potentially life-saving by allowing an interval for
the return of heart pumping function or providing a bridge
to heart transplantation, which may be required in the worst
case scenario (Duncan et al., 2001). Other suggested approaches
are immunosuppression, immunoglobulin, immunoadsorption,
and anti-viral treatment (Jensen and Marchant, 2016). However,
immunosuppressive therapy should be limited to giant cell
myocarditis and lymphocyticmyocarditis. The use of intravenous
immunoglobulin is not recommended currently. There is a
pressing need for drug development, and novel therapeutic
agents that can reduce viral entry into cardiomyocytes,
and viral-induced or host-mediate myocardial inflammation,
which would reduce the arrhythmic burden in this patient
population.
The use of animal models has advanced our understanding
of the mechanisms of arrhythmias and provide a platform
for assessing the efficacy of pharmacological therapy (Chen
et al., 2016; Choy et al., 2016; Tse et al., 2016a,b,c,h,i,l). Thus,
pre-clinical mouse studies have demonstrated the efficacy of
Chinese medicinal extracts such as QiHong and Qishaowuwei
formula in suppressing viral attachment and penetration, which
significantly ameliorated CVB3-induced myocardium necrosis
(Song et al., 2007; Fengqin et al., 2010). The benefits of traditional
Chinese medicines in viral myocarditis thus warrant further
investigation. Other novel therapies include mutation of the
viral genome to induce the expression of cytokines, such as
interferon-gamma, which can modulate the immune responses
and prevent inflammation (Henke et al., 2008). Modulation
of ion channel function may be useful for anti-arrhythmic
therapy. Triggered activity can be suppressed by reversing APD
prolongation and/or Ca2+ overload. Thus, EADs can be inhibited
the late INa (Belardinelli et al., 2013), whereas DADs could be
abolished by blocking RyR2 (Savio-Galimberti and Knollmann,
2015) or NCX (Sipido et al., 2006). KATP channel openers such
as mexiletine, with previously demonstrated cardioprotective
effects during ischaemia, could suppress APD prolongation
during acute myocarditis and may therefor protect against
Ca2+ overload, DADs and spatial heterogeneities in APDs
(Niwano et al., 2012).
In conclusion, viral myocarditis is an important cause of
mortality especially in infants, adolescents and young adults,
predisposing to life-threatening cardiac arrhythmias. Current
drug options are inadequate and are mainly supportive.
More efforts need to be devoted to the development
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of novel pharmacological agents that can prevent viral
invasion of cardiac tissue as well as viral- or host-induced
inflammation, and reducing arrhythmic complications of the
myocarditis.
AUTHOR CONTRIBUTIONS
GT: Design of manuscript; drafted and critically revised the
manuscript for important intellectual content; preparation
of figures. JY: Drafted and critically revised the manuscript
for important intellectual content. EL: Drafted and critically
revised the manuscript for important intellectual content.
BY: Interpreted primary research papers; critically revised the
manuscript for important intellectual content.
ACKNOWLEDGMENTS
GT was awarded a BBSRC Doctoral Training Award and thanks
for the Croucher Foundation for its generous support.
REFERENCES
Ahmed, M., Almilaji, A., Munoz, C., Elvira, B., Shumilina, E., Bock, C. T.,
et al. (2014). Down-regulation of K(+) channels by human parvovirus B19
capsid protein VP1. Biochem. Biophys. Res. Commun. 450, 1396–1401. doi:
10.1016/j.bbrc.2014.07.003
Ahmed, M., Elvira, B., Almilaji, A., Bock, C. T., Kandolf, R., and Lang, F.
(2015). Down-regulation of inwardly rectifying Kir2.1 K+ channels by human
parvovirus B19 capsid protein VP1. J. Membr. Biol. 248, 223–229. doi:
10.1007/s00232-014-9762-9
Ainger, L. E., Lawyer, N. G., and Fitch, C. W. (1966). Neonatal rubella myocarditis.
Br. Heart J. 28, 691–697. doi: 10.1136/hrt.28.5.691
Almilaji, A., Szteyn, K., Fein, E., Pakladok, T., Munoz, C., Elvira, B., et al.
(2013). Down-regulation of Na/K+ atpase activity by human parvovirus B19
capsid protein VP1. Cell. Physiol. Biochem. 31, 638–648. doi: 10.1159/000
350083
Alter, P., Grimm, W., and Maisch, B. (2001). Varicella myocarditis in an adult.
Heart 85:e2. doi: 10.1136/heart.85.1.e2
Andreoletti, L., Leveque, N., Boulagnon, C., Brasselet, C., and Fornes, P. (2009).
Viral causes of human myocarditis. Arch. Cardiovasc. Dis. 102, 559–568. doi:
10.1016/j.acvd.2009.04.010
Anzini, M., Merlo, M., Artico, J., and Sinagra, G. (2016). Arrhythmic
risk prediction of acute myocarditis presenting with life-threatening
ventricular tachyarrhythmias. Int. J. Cardiol. 212, 169–170. doi:
10.1016/j.ijcard.2016.03.020
Arbustini, E., Grasso, M., Diegoli, M., Percivalle, E., Grossi, P., Bramerio, M.,
et al. (1992). Histopathologic and molecular profile of human cytomegalovirus
infections in patients with heart transplants. Am. J. Clin. Pathol. 98, 205–213.
doi: 10.1093/ajcp/98.2.205
Arita, M., Ueno, Y., and Masuyama, Y. (1981). Complete heart block in mumps
myocarditis. Br. Heart J. 46, 342–344. doi: 10.1136/hrt.46.3.342
Babu-Narayan, S. V., McCarthy, K. P., Ho, S. Y., Magee, A. G., Kilner, P. J.,
and Sheppard, M. N. (2007). Myocarditis and sudden cardiac death in the
young: extensive fibrosis suggested by cardiovascular magnetic resonance
in vivo and confirmed post mortem. Circulation 116, e122–e125. doi:
10.1161/CIRCULATIONAHA.107.693085
Badorff, C., Lee, G. H., Lamphear, B. J., Martone, M. E., Campbell, K. P., Rhoads,
R. E., et al. (1999). Enteroviral protease 2A cleaves dystrophin: evidence of
cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 5, 320–326.
doi: 10.1038/6543
Baksi, A. J., Kanaganayagam, G. S., and Prasad, S. K. (2015). Arrhythmias in
viral myocarditis and pericarditis. Card. Electrophysiol. Clin. 7, 269–281. doi:
10.1016/j.ccep.2015.03.009
Basso, C., Calabrese, F., Angelini, A., Carturan, E., and Thiene, G. (2013).
Classification and histological, immunohistochemical, and molecular diagnosis
of inflammatory myocardial disease. Heart Fail. Rev. 18, 673–681. doi:
10.1007/s10741-012-9355-6
Belardinelli, L., Liu, G., Smith-Maxwell, C., Wang, W. Q., El-Bizri, N., Hirakawa,
R., et al. (2013). A novel, potent, and selective inhibitor of cardiac late sodium
current suppresses experimental arrhythmias. J. Pharmacol. Exp. Ther. 344,
23–32. doi: 10.1124/jpet.112.198887
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas,
A., Hong, J. S., et al. (1997). Isolation of a common receptor for
Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320–1323. doi:
10.1126/science.275.5304.1320
Biocic, S., Durasevic, Z., Starcevic, B., and Udovicic, M. (2009). [Varicella zoster
myopericarditis in an immunocompetent adult]. Acta Med. Croatica 63,
325–327.
Bowles, N. E., Ni, J., Kearney, D. L., Pauschinger, M., Schultheiss, H. P., McCarthy,
R., et al. (2003). Detection of viruses in myocardial tissues by polymerase
chain reaction. Evidence of adenovirus as a common cause of myocarditis
in children and adults. J. Am. Coll. Cardiol. 42, 466–472. doi: 10.1016/s0735-
1097(03)00648-x
Bultmann, B. D., Klingel, K., Sotlar, K., Bock, C. T., Baba, H. A., Sauter, M.,
et al. (2003). Fatal parvovirus B19-associated myocarditis clinically mimicking
ischemic heart disease: an endothelial cell-mediated disease. Hum. Pathol. 34,
92–95. doi: 10.1053/hupa.2003.48
Caruso, A., Rotola, A., Comar, M., Favilli, F., Galvan, M., Tosetti, M., et al.
(2002). HHV-6 infects human aortic and heart microvascular endothelial cells,
increasing their ability to secrete proinflammatory chemokines. J. Med. Virol.
67, 528–533. doi: 10.1002/jmv.10133
Casey, C. G., Iskander, J. K., Roper, M. H., Mast, E. E., Wen, X. J., Torok,
T. J., et al. (2005). Adverse events associated with smallpox vaccination
in the United States, January–October 2003. JAMA 294, 2734–2743. doi:
10.1001/jama.294.21.2734
Chan, G., Nogalski, M. T., Stevenson, E. V., and Yurochko, A. D. (2012).
Human cytomegalovirus induction of a unique signalsome during viral entry
into monocytes mediates distinct functional changes: a strategy for viral
dissemination. J. Leukoc. Biol. 92, 743–752. doi: 10.1189/jlb.0112040
Cheetham, H. D., Hart, J., Coghill, N. F., and Fox, B. (1970). Rabies with
myocarditis. Lancet 295, 921–922. doi: 10.1016/S0140-6736(70)91048-2
Chen, Z., Sun, B., Tse, G., Jiang, J., and Xu, W. (2016). Reversibility of both
sinus node dysfunction and reduced HCN4 mRNA expression level in an
atrial tachycardia pacing model of tachycardia-bradycardia syndrome in rabbit
hearts. Int. J. Clin. Exp. Pathol.
Chimenti, C., Russo, A., Pieroni, M., Calabrese, F., Verardo, R., Thiene, G., et al.
(2004). Intramyocyte detection of Epstein-Barr virus genome by laser capture
microdissection in patients with inflammatory cardiomyopathy. Circulation
110, 3534–3539. doi: 10.1161/01.CIR.0000148823.08092.0E
Choy, L., Yeo, J. M., Tse, V., Chan, S. P., and Tse, G. (2016). Cardiac disease and
arrhythmogenesis: mechanistic insights from mouse models. Int. J. Cardiol.
Heart. Vasc. 12, 1–10. doi: 10.1016/j.ijcha.2016.05.005
De, A., Myridakis, D., Kerrigan, M., and Kiblawi, F. (2011). Varicella
myopericarditis mimicking myocardial infarction in a 17-year-old boy. Tex.
Heart Inst. J. 38, 288–290.
Duncan, B. W., Bohn, D. J., Atz, A. M., French, J. W., Laussen, P. C., and Wessel,
D. L. (2001). Mechanical circulatory support for the treatment of children with
acute fulminant myocarditis. J. Thorac. Cardiovasc. Surg. 122, 440–448. doi:
10.1067/mtc.2001.115243
Eisenhut, M. (2006). Extrapulmonary manifestations of severe respiratory
syncytial virus infection – a systematic review. Crit. Care 10, R107. doi:
10.1186/cc4984
Eloff, B. C., Lerner, D. L., Yamada, K. A., Schuessler, R. B., Saffitz, J. E., and
Rosenbaum, D. S. (2001). High resolution optical mapping reveals conduction
slowing in connexin43 deficient mice. Cardiovasc. Res. 51, 681–690. doi:
10.1016/S0008-6363(01)00341-8
Frontiers in Physiology | www.frontiersin.org 7 July 2016 | Volume 7 | Article 308
Tse et al. Arrhythmogenic Mechanisms in Viral Myocarditis
Felker, G. M., Boehmer, J. P., Hruban, R. H., Hutchins, G. M., Kasper, E. K.,
Baughman, K. L., et al. (2000). Echocardiographic findings in fulminant and
acute myocarditis. J. Am. Coll. Cardiol. 36, 227–232. doi: 10.1016/S0735-
1097(00)00690-2
Fengqin, L., Yulin, W., Xiaoxin, Z., Youpeng, J., Yan, C., Qing-qing, W., et al.
(2010). The heart-protective mechanism of Qishaowuwei formula on murine
viral myocarditis induced by CVB3. J. Ethnopharmacol. 127, 221–228. doi:
10.1016/j.jep.2009.11.017
Fung, G., Luo, H., Qiu, Y., Yang, D., and McManus, B. (2016). Myocarditis. Circ.
Res. 118, 496–514. doi: 10.1161/CIRCRESAHA.115.306573
Gaaloul, I., Riabi, S., Evans, M., Hunter, T., Huber, S., and Aouni, M.
(2016). Postmortem diagnosis of infectious heart diseases: a mystifying
cause of Sudden Infant Death. Forensic Sci. Int. 262, 166–172. doi:
10.1016/j.forsciint.2016.03.002
Gaaloul, I., Riabi, S., Harrath, R., Evans, M., Salem, N. H., Mlayeh, S., et al. (2012).
Sudden unexpected death related to enterovirus myocarditis: histopathology,
immunohistochemistry and molecular pathology diagnosis at post-mortem.
BMC Infect. Dis. 12:212. doi: 10.1186/1471-2334-12-212
George, S. A., Sciuto, K. J., Lin, J., Salama, M. E., Keener, J. P., Gourdie, R.
G., et al. (2015). Extracellular sodium and potassium levels modulate cardiac
conduction in mice heterozygous null for the Connexin43 gene. Pflugers Arch.
467, 2287–2297. doi: 10.1007/s00424-015-1698-0
Guerrero, P. A., Schuessler, R. B., Davis, L. M., Beyer, E. C., Johnson, C.
M., Yamada, K. A., et al. (1997). Slow ventricular conduction in mice
heterozygous for a connexin43 null mutation. J. Clin. Invest. 99, 1991–1998.
doi: 10.1172/JCI119367
Guo, J. G. (2008). [Detection of cardiac troponin and high-sensitivity C reactive
protein in children with viral myocarditis].Nan Fang Yi Ke Da Xue Xue Bao 28,
1076–1077. doi: 10.1007/s00246-010-9814-6
Hemida, M. G., Ye, X., Zhang, H. M., Hanson, P. J., Liu, Z., McManus, B.
M., et al. (2013). MicroRNA-203 enhances coxsackievirus B3 replication
through targeting zinc finger protein-148. Cell. Mol. Life Sci. 70, 277–291. doi:
10.1007/s00018-012-1104-4
Henke, A., Jarasch, N., Martin, U., Wegert, J., Wildner, A., Zell, R., et al.
(2008). Recombinant coxsackievirus vectors for prevention and therapy
of virus-induced heart disease. Int. J. Med. Microbiol. 298, 127–134. doi:
10.1016/j.ijmm.2007.08.010
Heymans, S. (2006). Inflammation and cardiac remodeling during viral
myocarditis. Ernst Schering Res. Found. Workshop 55, 197–218. doi: 10.1007/3-
540-30822-9_12
Hsieh, Y. C., Lin, J. C., Hung, C. Y., Li, C. H., Lin, S. F., Yeh, H. I., et al. (2016).
Gap junction modifier rotigaptide decreases the susceptibility to ventricular
arrhythmia by enhancing conduction velocity and suppressing discordant
alternans during therapeutic hypothermia in isolated rabbit hearts. Heart
Rhythm. 13, 251–261. doi: 10.1016/j.hrthm.2015.07.023
Hsieh, Y. C., Lin, S. F., Huang, J. L., Hung, C. Y., Lin, J. C., Liao, Y. C., et al.
(2014). Moderate hypothermia (33C) decreases the susceptibility to pacing-
induced ventricular fibrillation compared with severe hypothermia (30C) by
attenuating spatially discordant alternans in isolated rabbit hearts. Acta Cardiol
Sin. 30, 455–465.
Hsieh, Y. C., Lin, S. F., Lin, T. C., Ting, C. T., and Wu, T. J. (2009). Therapeutic
hypothermia (30 degrees C) enhances arrhythmogenic substrates, including
spatially discordant alternans, and facilitates pacing-induced ventricular
fibrillation in isolated rabbit hearts.Circ. J. 73, 2214–2222. doi: 10.1253/circj.CJ-
09-0432
Huang, M., Bigos, D., and Levine, M. (1998). Ventricular arrhythmia associated
with respiratory syncytial viral infection. Pediatr. Cardiol. 19, 498–500. doi:
10.1007/s002469900369
Hughes, S. A., Thaker, H. M., and Racaniello, V. R. (2003). Transgenic mouse
model for echovirus myocarditis and paralysis. Proc. Natl. Acad. Sci. U.S.A. 100,
15906–15911. doi: 10.1073/pnas.2535934100
January, C. T., Riddle, J. M., and Salata, J. J. (1988). A model for early
afterdepolarizations: induction with the Ca2+ channel agonist Bay K 8644.
Circ. Res. 62, 563–571. doi: 10.1161/01.RES.62.3.563
Jensen, L. D., and Marchant, D. J. (2016). Emerging pharmacologic targets
and treatments for myocarditis. Pharmacol. Ther. 161, 40–51. doi:
10.1016/j.pharmthera.2016.03.006
Juhasz, Z., Tiszlavicz, L., Kele, B., Terhes, G., Deak, J., Rudas, L., et al.
(2014). Sudden cardiac death from parvovirus B19 myocarditis in a
young man with Brugada syndrome. J. Forensic Leg. Med. 25, 8–13. doi:
10.1016/j.jflm.2014.04.018
Kallianos, K., Moraes, G. L., and Ordovas, K. G. (2015). Prognostic role of MR
imaging in nonischemicmyocardial disease.Magn. Reson. Imaging Clin. N. Am.
23, 89–94. doi: 10.1016/j.mric.2014.09.004
Karjalainen, J., Heikkila, J., Nieminen, M. S., Jalanko, H., Kleemola, M.,
Lapinleimu, K., et al. (1983). Etiology of mild acute infectious myocarditis.
relation to clinical features. Acta Med. Scand. 213, 65–73. doi: 10.1111/j.0954-
6820.1983.tb03692.x
Kindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A.,
et al. (2012). Update on Myocarditis. J. Am. Coll. Cardiol. 59, 779–792. doi:
10.1016/j.jacc.2011.09.074
Kriseman, T. (1984). Rubella myocarditis in a 9-year-old patient. Clin. Pediatr. 23,
240–241. doi: 10.1177/000992288402300413
Kühl, U., Pauschinger, M., Noutsias, M., Seeberg, B., Bock, T., Lassner, D.,
et al. (2005). High prevalence of viral genomes and multiple viral infections
in the myocardium of adults with “idiopathic” left ventricular dysfunction.
Circulation 111, 887–893. doi: 10.1161/01.CIR.0000155616.07901.35
Laake, H. (1951).Myocarditis in Poliomyelitis.ActaMed. Scand. 140, 159–169. doi:
10.1111/j.0954-6820.1951.tb10168.x
Liao, P.-H., Hsu, Y.-H., Yang, H.-H., Wang, M.-H., and Chen, L.-K. (2012).
Involvement of extraneural tissues and upregulation of inducible nitric oxide
synthase after experimental infection with rabies virus in BALB/c mice and
LEW/SsN rats. Pathol. Int. 62, 619–627. doi: 10.1111/j.1440-1827.2012.02846.x
Lin, J., and Keener, J. P. (2013). Ephaptic coupling in cardiac myocytes. IEEE Trans.
Biomed. Eng. 60, 576–582. doi: 10.1109/TBME.2012.2226720
Lin, J., and Keener, J. P. (2014). Microdomain effects on transverse cardiac
propagation. Biophys. J. 106, 925–931. doi: 10.1016/j.bpj.2013.11.1117
Lupescu, A., Bock, C. T., Lang, P. A., Aberle, S., Kaiser, H., Kandolf, R., et al.
(2006). Phospholipase A2 Activity-Dependent Stimulation of Ca(2+) Entry by
Human Parvovirus B19 Capsid Protein VP1. J. Virol. 80, 11370–11380. doi:
10.1128/JVI.01041-06
Lupescu, A., Geiger, C., Zahir, N., Aberle, S., Lang, P. A., Kramer, S., et al. (2009).
Inhibition of Na+/H+ exchanger activity by parvovirus B19 protein NS1. Cell.
Physiol. Biochem. 23, 211–220. doi: 10.1159/000204110
Martino, T. A., Petric, M., Brown, M., Aitken, K., Gauntt, C. J., Richardson, C. D.,
et al. (1998). Cardiovirulent coxsackieviruses and the decay-accelerating factor
(CD55) receptor. Virology 244, 302–314. doi: 10.1006/viro.1998.9122
Matsumori, A. (2012). Myocarditis: past, present and future. Kitasato Med. J. 42,
3–7.
Matsumori, A., Yutani, C., Ikeda, Y., Kawai, S., and Sasayama, S. (2000). Hepatitis
C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab.
Invest. 80, 1137–1142. doi: 10.1038/labinvest.3780120
Mavrogeni, S., Petrou, E., Kolovou, G., Theodorakis, G., and Iliodromitis,
E. (2013). Prediction of ventricular arrhythmias using cardiovascular
magnetic resonance. Eur. Heart J. Cardiovasc. Imaging 14, 518–525. doi:
10.1093/ehjci/jes302
Morley, G. E., Vaidya, D., Samie, F. H., Lo, C., Delmar, M., and Jalife, J. (1999).
Characterization of conduction in the ventricles of normal and heterozygous
Cx43 knockout mice using optical mapping. J. Cardiovasc. Electrophysiol. 10,
1361–1375. doi: 10.1111/j.1540-8167.1999.tb00192.x
Neilan, T. G., Farhad, H., Mayrhofer, T., Shah, R. V., Dodson, J. A., Abbasi, S. A.,
et al. (2015). Late gadolinium enhancement among survivors of sudden cardiac
arrest. JACC Cardiovasc. Imaging 8, 414–423. doi: 10.1016/j.jcmg.2014.11.017
Nerbonne, J. M. (2000). Molecular basis of functional voltage-gated K+ channel
diversity in the mammalian myocardium. J. Physiol. 525, 285–298. doi:
10.1111/j.1469-7793.2000.t01-1-00285.x
Niwano, S., Hirasawa, S., Niwano, H., Sasaki, S., Masuda, R., Sato, K., et al. (2012).
Cardioprotective effects of sarcolemmal and mitochondrial K-ATP channel
openers in an experimental model of autoimmune myocarditis. Role of the
reduction in calcium overload during acute heart failure. Int. Heart J. 53,
139–145. doi: 10.1536/ihj.53.139
Orom, U. A., Nielsen, F. C., and Lund, A. H. (2008). MicroRNA-10a binds the
5′UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell
30, 460–471. doi: 10.1016/j.molcel.2008.05.001
Frontiers in Physiology | www.frontiersin.org 8 July 2016 | Volume 7 | Article 308
Tse et al. Arrhythmogenic Mechanisms in Viral Myocarditis
Osadchii, O. E. (2010). Mechanisms of hypokalemia-induced ventricular
arrhythmogenicity. Fundam. Clin. Pharmacol. 24, 547–559. doi:
10.1111/j.1472-8206.2010.00835.x
Osadchii, O. E. (2014). Impact of hypokalemia on electromechanical window,
excitation wavelength and repolarization gradients in guinea-pig and rabbit
hearts. PLoS ONE 9:e105599. doi: 10.1371/journal.pone.0105599
Pan, H. Y., Yamada, H., Chida, J., Wang, S., Yano, M., Yao, M., et al.
(2011). Up-regulation of ectopic trypsins in the myocardium by influenza A
virus infection triggers acute myocarditis. Cardiovasc. Res. 89, 595–603. doi:
10.1093/cvr/cvq358
Park, H., Park, H., Lee, D., Oh, S., Lim, J., Hwang, H. J., et al. (2014a).
Increased phosphorylation of Ca(2+) handling proteins as a proarrhythmic
mechanism in myocarditis. Circ. J. 78, 2292–2301. doi: 10.1253/circj.CJ-
14-0277
Park, H., Park, H., Lim, J., Oh, S., Park, S., Pak, H. M., et al. (2014b).
Arrhythmogenic mechanisms of autoimmune myocarditis associated with
inflammation and Ca2+/calmodulin-dependent protein kinase II activation.
Int. J. Arrhythm. 15, 4–16.
Pasquié, J. L. (2005). May Fever Trigger Ventricular Fibrillation? Indian Pacing
Electrophysiol. J. 5, 139–145.
Patane, S., and Marte, F. (2010). Revelation of Brugada electrocardiographic
pattern during a febrile state associated with acute myocardial infarction. Int. J.
Cardiol. 144, e1–e4. doi: 10.1016/j.ijcard.2008.12.037
Patane, S., Marte, F., La Rosa, F. C., Albanese, A., La Rocca, R., and Villari,
S. A. (2010). Revelation of Brugada electrocardiographic pattern during
a febrile state. Int. J. Cardiol. 140, e19–e21. doi: 10.1016/j.ijcard.2008.
11.069
Pauschinger, M., Chandrasekharan, K., and Schultheiss, H. P. (2004). Myocardial
remodeling in viral heart disease: possible interactions between inflammatory
mediators and MMP-TIMP system. Heart Fail. Rev. 9, 21–31. doi:
10.1023/B:HREV.0000011391.81676.3c
Petryka, J., Baksi, A. J., Prasad, S. K., Pennell, D. J., and Kilner, P. J. (2014).
Prevalence of inferobasal myocardial crypts among patients referred for
cardiovascular magnetic resonance. Circ. Cardiovasc. Imaging 7, 259–264. doi:
10.1161/CIRCIMAGING.113.001241
Porter, H. J., Quantrill, A. M., and Fleming, K. A. (1988). B19 parvovirus infection
of myocardial cells. Lancet 1, 535–536. doi: 10.1016/S0140-6736(88)91332-3
Priori, S. G., and Corr, P. B. (1990). Mechanisms underlying early and delayed
afterdepolarizations induced by catecholamines. Am. J. Physiol. 258, H1796–
H1805.
Reis, F. J., Viana, M., Oliveira, M., Sousa, T. A., and Parana, R. (2007). Prevalence
of hepatitis C and B virus infection in patients with idiopathic dilated
cardiomyopathy in Brazil: a pilot study. Braz. J. Infect. Dis. 11, 318–321. doi:
10.1590/S1413-86702007000300004
Rezkalla, S. H., and Kloner, R. A. (2010). Influenza-related viral myocarditis.WMJ
109, 209–213.
Rhett, J. M., and Gourdie, R. G. (2012). The perinexus: a new feature
of Cx43 gap junction organization. Heart Rhythm 9, 619–623. doi:
10.1016/j.hrthm.2011.10.003
Rhett, J. M., Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2013). The
perinexus: sign-post on the path to a new model of cardiac conduction? Trends
Cardiovasc. Med. 23, 222–228. doi: 10.1016/j.tcm.2012.12.005
Rich, R., and McErlean, M. (1993). Complete heart block in a child with varicella.
Am. J. Emerg. Med. 11, 602–605. doi: 10.1016/0735-6757(93)90011-Y
Rong, Q., Huang, J., Su, E., Li, J., Li, J., Zhang, L., et al. (2007). Infection of hepatitis
B virus in extrahepatic endothelial tissues mediated by endothelial progenitor
cells. Virol. J. 4, 1–14. doi: 10.1186/1743-422X-4-36
Rosenberg, D. H. (1945). Electrocardiographic Changes in Epidemic Parotitis
(Mumps). Exp. Biol. Med. 58, 9–11. doi: 10.3181/00379727-58-14819
Ross, E., and Armentrout, S. A. (1962). Myocarditis Associated with Rabies. N.
Engl. J. Med. 266, 1087–1089. doi: 10.1056/NEJM196205242662105
Saito, J., Niwano, S., Niwano, H., Inomata, T., Yumoto, Y., Ikeda, K., et al.
(2002). Electrical remodeling of the ventricular myocardium in myocarditis:
studies of rat experimental autoimmune myocarditis. Circ. J. 66, 97–103. doi:
10.1253/circj.66.97
Salerno, F., Girerd, N., Chalabreysse, L., Billaud, G., Lina, B., and Chevalier, P.
(2011). Myocarditis and cardiac channelopathies: a deadly association? Int. J.
Cardiol. 147, 468–470. doi: 10.1016/j.ijcard.2011.01.019
Sanguineti, F., Garot, P., Mana, M., O’H-Ici, D., Hovasse, T., Unterseeh, T., et al.
(2015). Cardiovascular magnetic resonance predictors of clinical outcome in
patients with suspected acute myocarditis. J. Cardiovasc. Magn. Reson. 17, 78.
doi: 10.1186/s12968-015-0185-2
Savio-Galimberti, E., and Knollmann, B. C. (2015). Channel activity of cardiac
ryanodine receptors (RyR2) determines potency and efficacy of flecainide
and r-propafenone against arrhythmogenic calcium waves in ventricular
cardiomyocytes. PLoS ONE 10:e0131179. doi: 10.1371/journal.pone.01
31179
Savon, C., Acosta, B., Valdes, O., Goyenechea, A., Gonzalez, G., Pinon, A., et al.
(2008). A myocarditis outbreak with fatal cases associated with adenovirus
subgenera C among children from Havana City in 2005. J. Clin. Virol. 43,
152–157. doi: 10.1016/j.jcv.2008.05.012
Shaboodien, G., Maske, C., Wainwright, H., Smuts, H., Ntsekhe, M., Commerford,
P. J., et al. (2013). Prevalence of myocarditis and cardiotropic virus
infection in Africans with HIV-associated cardiomyopathy, idiopathic
dilated cardiomyopathy and heart transplant recipients: a pilot study:
cardiovascular topic. Cardiovasc. J. Afr. 24, 218–223. doi: 10.5830/CVJA-
2013-039
Shimizu, W., Aiba, T., and Kamakura, S. (2005). Mechanisms of disease: current
understanding and future challenges in Brugada syndrome. Nat. Clin. Pract.
Cardiovasc. Med. 2, 408–414. doi: 10.1038/ncpcardio0268
Sipido, K. R., Varro, A., and Eisner, D. (2006). Sodium calcium exchange as a
target for antiarrhythmic therapy. Handb. Exp. Pharmacol. 171, 159–199. doi:
10.1007/3-540-29715-4_6
Smeets, J. L., Allessie, M. A., Lammers, W. J., Bonke, F. I., and Hollen, J. (1986).
The wavelength of the cardiac impulse and reentrant arrhythmias in isolated
rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and
potassium. Circ. Res. 58, 96–108. doi: 10.1161/01.RES.58.1.96
Song, X., Liu, Z., Wang, H., Xin, Y., Wang, X., Chen, J., et al. (2007). QiHong
prevents death in coxsackievirus B3 induced murine myocarditis through
inhibition of virus attachment and penetration. Exp. Biol. Med. (Maywood) 232,
1441–1448. doi: 10.3181/0704-RM-110
Spray, D. C., and Burt, J. M. (1990). Structure-activity relationships of the cardiac
gap junction channel. Am. J. Physiol. 258, C195–C205.
Stein, M., van Veen, T. A., Hauer, R. N., de Bakker, J. M., and van Rijen, H. V.
(2011). A 50% reduction of excitability but not of intercellular coupling affects
conduction velocity restitution and activation delay in the mouse heart. PLoS
ONE 6:e20310. doi: 10.1371/journal.pone.0020310
Stein, M., van Veen, T. A., Remme, C. A., Boulaksil, M., Noorman, M., van
Stuijvenberg, L., et al. (2009). Combined reduction of intercellular coupling and
membrane excitability differentially affects transverse and longitudinal cardiac
conduction. Cardiovasc. Res. 83, 52–60. doi: 10.1093/cvr/cvp124
Steinberger, J., Lucas, R. V. Jr., Edwards, J. E., and Titus, J. L. (1996). Causes of
sudden unexpected cardiac death in the first two decades of life. Am. J. Cardiol.
77, 992–995. doi: 10.1016/S0002-9149(96)00035-5
Steinke, K., Sachse, F., Ettischer, N., Strutz-Seebohm, N., Henrion, U., Rohrbeck,
M., et al. (2013). Coxsackievirus B3 modulates cardiac ion channels. FASEB J.
27, 4108–4121. doi: 10.1096/fj.13-230193
Strauss, D. G., andWu, K. C. (2009). Imaging myocardial scar and arrhythmic risk
prediction–a role for the electrocardiogram? J. Electrocardiol. 42, 138 e131–138
e138. doi: 10.1016/j.jelectrocard.2008.12.010
Tang, Q., Huang, J., Qian, H., Chen, L., Wang, T., Wang, H., et al.
(2007). Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is
mediated by improving myocardial repolarization. Life Sci. 80, 601–608. doi:
10.1016/j.lfs.2006.11.045
Tavora, F., Gonzalez-Cuyar, L. F., Dalal, J. S., O’Malley,M. T., Zhao, R., Peng, H. Q.,
et al. (2008). Fatal parvoviral myocarditis: a case report and review of literature.
Diagn. Pathol. 3, 1–6. doi: 10.1186/1746-1596-3-21
Thomas, S. A., Schuessler, R. B., Berul, C. I., Beardslee, M. A., Beyer, E. C.,
Mendelsohn, M. E., et al. (1998). Disparate effects of deficient expression
of connexin43 on atrial and ventricular conduction: evidence for chamber-
specific molecular determinants of conduction. Circulation 97, 686–691. doi:
10.1161/01.CIR.97.7.686
Tomari, Y., and Zamore, P. D. (2005). Perspective: machines for RNAi. Genes Dev.
19, 517–529. doi: 10.1101/gad.1284105
Tominaga, M., Matsumori, A., Horie, M., Yoshida, H., and Okada, Y.
(1993). Activation of Ca-permeable cation channels by myocarditis-associated
Frontiers in Physiology | www.frontiersin.org 9 July 2016 | Volume 7 | Article 308
Tse et al. Arrhythmogenic Mechanisms in Viral Myocarditis
antibody in guinea pig ventricular myocytes. J. Clin. Invest. 91, 1231–1234. doi:
10.1172/JCI116285
Tong, L., Lin, L., Wu, S., Guo, Z., Wang, T., Qin, Y., et al. (2013). MiR-10a∗ up-
regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence.
Nucleic Acids Res. 41, 3760–3771. doi: 10.1093/nar/gkt058
Tse, G. (2015). Mechanisms of Cardiac Arrhythmias. J. Arrhythm. 32, 75–81. doi:
10.1016/j.joa.2015.11.003
Tse, G. (2016a). Both transmural dispersion of repolarization and transmural
dispersion of refractoriness are poor predictors of arrhythmogenicity: A role
for the index of Cardiac Electrophysiological Balance (QT/QRS)? J. Geriatr.
Cardiol.
Tse, G. (2016b). Novel conduction-repolarization indices for the stratification of
arrhythmic risk. J. Geriatr. Cardiol.
Tse, G. (2016c). (Tpeak-Tend)/QRS and (Tpeak-Tend)/(QT x QRS): novel
markers for predicting arrhythmic risk in Brugada syndrome. Europace. doi:
10.17863/CAM.113
Tse, G., Ali, A., Alpendurada, F., Prasad, S., Raphael, C. E., and Vassiliou, V.
(2015a). Tuberculous constrictive pericarditis. Res. Cardiovasc. Med. 4:e29614.
doi: 10.5812/cardiovascmed.29614
Tse, G., Ali, A., Prasad, S. K., Vassiliou, V., and Raphael, C. E. (2015b).
Atypical case of post-partum cardiomyopathy: an overlap syndrome with
arrhythmogenic right ventricular cardiomyopathy? BJR Case Rep. 1, 20150182.
doi:10.1259/bjrcr.20150182
Tse, G., Hothi, S. S., Grace, A. A., and Huang, C. L. (2012). Ventricular
arrhythmogenesis following slowed conduction in heptanol-treated,
Langendorff-perfused mouse hearts. J. Physiol. Sci. 62, 79–92. doi:
10.1007/s12576-011-0187-2
Tse, G., Lai, E. T., Lee, A. P., Yan, B. P., and Wong, S. H. (2016a).
Electrophysiological mechanisms of gastrointestinal arrhythmogenesis:
lessons from the heart. Front. Physiol. 7:230. doi: 10.3389/fphys.2016.
00230
Tse, G., Lai, E. T., Tse, V., and Yeo, J. M. (2016b). Molecular and
electrophysiological mechanisms underlying cardiac arrhythmogenesis in
diabetes mellitus. J. Diabetes Res.
Tse, G., Lai, E. T., Yeo, J. M., and Yan, B. P. (2016c). Electrophysiological
mechanisms of Bayés syndrome: insights from clinical and mouse studies.
Front. Physiol. 7:188. doi: 10.3389/fphys.2016.00188
Tse, G., Lai, T. H., Yeo, J. M., Tse, V., and Wong, S. H. (2016d). Mechanisms
of electrical activation and conduction in the gastrointestinal system: lessons
from cardiac electrophysiology. Front. Physiol. 7:182. doi: 10.3389/fphys.2016.
00182
Tse, G., Sun, B., Wong, S. T., Tse, V., and Yeo, J. M. (2016e). Ventricular anti-
arrhythmic effects of hypercalcaemia treatment in hyperkalaemic, Langendorff-
perfused mouse hearts. Biomed. Rep. doi: 10.3892/br.2016.577
Tse, G., Tse, V., and Yeo, J. M. (2016f). Ventricular anti-arrhythmic effects of
heptanol in hypokalaemic, Langendorff-perfused mouse hearts. Biomed Rep.
4, 313–324. doi: 10.3892/br.2016.577
Tse, G., Tse, V., Yeo, J. M., and Sun, B. (2016g). Atrial anti-arrhythmic effects of
heptanol in Langendorff-perfused mouse hearts. PLoS ONE. 11:e0148858. doi:
10.1371/journal.pone.0148858
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016h). Depolarization vs.
repolarization: what is the mechanism of ventricular arrhythmogenesis
underlying sodium channel haploinsufficiency in mouse hearts? Acta Physiol
(Oxf). doi: 10.1111/apha.12694. [Epub ahead of print].
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016i). Determination of action
potential wavelength restitution in Scn5a+/− mouse hearts modelling human
Brugada syndrome. J. Physiol.
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016j). Monophasic action potential
recordings: which is the recording electrode? J. Basic Clin. Physiol. Pharmacol.
doi: 10.1515/jbcpp-2016-0007. [Epub ahead of print].
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016k). Restitution analysis of
alternans using dynamic pacing and its comparison with S1S2 restitution in
heptanol-treated, hypokalaemic Langendorff-perfused mouse hearts. Biomed.
Rep. 4, 673–680. doi: 10.3892/br.2016.659
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016l). Variability in local action
potential durations, dispersion of repolarization and wavelength restitution
in aged wild-type and Scn5a+/− mouse hearts modelling human Brugada
syndrome. J. Geriatr. Cardiol.
Tse, G., Wong, S. T. T. V., Lee, Y. T., Lin, H. Y., and Yeo, J. M.
(2016m). Cardiac dynamics: alternans and arrhythmogenesis. J. Arrhythm. doi:
10.1016/j.joa.2016.02.009
Tse, G., and Yan, B. P. (2016a). Novel arrhythmic risk markers incorporating QRS
dispersion: QRSd x (Tpeak-Tend) / QRS and QRSd x (Tpeak-Tend) / (QT x
QRS). Ann. Noninvasive Electrocardiol.
Tse, G., and Yan, B. P. (2016b). Traditional and novel electrocardiographic markers
for predicting arrhythmic risk and sudden cardiac death. Europace.
Tse, G., Yan, B. P., Chan, Y.W., Tian, X. Y., andHuang, Y. (2016n). Reactive oxygen
species, endoplasmic reticulum stress and mitochondrial dysfunction: the link
with cardiac arrhythmogenesis. Front. Physiol. 7:313. doi: 10.3389/fphys.2016.
00313
Tse, G., and Yeo, J. M. (2015). Conduction abnormalities and ventricular
arrhythmogenesis: the roles of sodium channels and gap junctions. Int. J.
Cardiol. Heart Vasc. 9, 75–82. doi: 10.1016/j.ijcha.2015.10.003
Tse, G., Yeo, J. M., Tse, V., and Sun, B. (2016o). Gap junction inhibition by
heptanol increases ventricular arrhythmogenicity by decreasing conduction
velocity without affecting repolarization properties ormyocardial refractoriness
in Langendorff-perfused mouse hearts.Mol. Med. Rep.
Ukimura, A., Satomi, H., Ooi, Y., and Kanzaki, Y. (2012). Myocarditis
associated with influenza A H1N1pdm2009. Influenza Res. Treat. 2012, 8. doi:
10.1155/2012/351979
Vaidya, D., Morley, G. E., Samie, F. H., and Jalife, J. (1999). Reentry and fibrillation
in the mouse heart. A challenge to the critical mass hypothesis. Circ. Res. 85,
174–181. doi: 10.1161/01.RES.85.2.174
Vaidya, D., Tamaddon, H. S., Lo, C. W., Taffet, S. M., Delmar, M., Morley, G.
E., et al. (2001). Null mutation of connexin43 causes slow propagation of
ventricular activation in the late stages of mouse embryonic development. Circ.
Res. 88, 1196–1202. doi: 10.1161/hh1101.091107
Valdes, O., Acosta, B., Pinon, A., Savon, C., Goyenechea, A., Gonzalez, G., et al.
(2008). First report on fatal myocarditis associated with adenovirus infection in
Cuba. J. Med. Virol. 80, 1756–1761. doi: 10.1002/jmv.21274
van Rijen, H. V., Eckardt, D., Degen, J., Theis, M., Ott, T., Willecke,
K., et al. (2004). Slow conduction and enhanced anisotropy increase
the propensity for ventricular tachyarrhythmias in adult mice with
induced deletion of connexin43. Circulation 109, 1048–1055. doi:
10.1161/01.CIR.0000117402.70689.75
Vassiliou, V., Chin, C., Perperoglou, A., Tse, G., Ali, A., Raphael, C., et al.
(2014). 93 Ejection fraction by cardiovascular magnetic resonance predicts
adverse outcomes post aortic valve replacement. Heart 100, A53–A54. doi:
10.1136/heartjnl-2014-306118.93
Veeraraghavan, R., Lin, J., Hoeker, G. S., Keener, J. P., Gourdie, R. G., and Poelzing,
S. (2015). Sodium channels in the Cx43 gap junction perinexus may constitute
a cardiac ephapse: an experimental and modeling study. Pflugers Arch. 467,
2093–2105. doi: 10.1007/s00424-014-1675-z
Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2014a). Intercellular electrical
communication in the heart: a new, active role for the intercalated disk. Cell
Commun. Adhes. 21, 161–167. doi: 10.3109/15419061.2014.905932
Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2014b). Novel ligands
for zipping and unzipping the intercalated disk: today’s experimental tools,
tomorrow’s therapies? Cardiovasc. Res. 104, 229–230. doi: 10.1093/cvr/cvu216
Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2014c). Old cogs, new tricks:
a scaffolding role for connexin43 and a junctional role for sodium channels?
FEBS Lett. 588, 1244–1248. doi: 10.1016/j.febslet.2014.01.026
Veeraraghavan, R., Salama, M. E., and Poelzing, S. (2012). Interstitial
volume modulates the conduction velocity-gap junction relationship. Am.
J. Physiol. Heart Circ. Physiol. 302, H278–H286. doi: 10.1152/ajpheart.008
68.2011
Venkat Raman, G., Prosser, A., Spreadbury, P. L., Cockcroft, P.M., andOkubadejo,
O. A. (1988). Rabies presenting with myocarditis and encephalitis. J. Infect. 17,
155–158. doi: 10.1016/S0163-4453(88)91767-7
Wakisaka, Y., Niwano, S., Niwano, H., Saito, J., Yoshida, T., Hirasawa, S.,
et al. (2004). Structural and electrical ventricular remodeling in rat acute
myocarditis and subsequent heart failure. Cardiovasc. Res. 63, 689–699. doi:
10.1016/j.cardiores.2004.04.020
Woolf, P. K., Chung, T. S., Stewart, J., Lialios, M., Davidian, M., and Gewitz, M. H.
(1987). Life-threatening dysrhythmias in varicella myocarditis. Clin. Pediatr.
(Phila) 26, 480–482. doi: 10.1177/000992288702600911
Frontiers in Physiology | www.frontiersin.org 10 July 2016 | Volume 7 | Article 308
Tse et al. Arrhythmogenic Mechanisms in Viral Myocarditis
Xu, H. F., Ding, Y. J., Shen, Y. W., Xue, A. M., Xu, H. M., Luo, C. L., et al.
(2012). MicroRNA- 1 represses Cx43 expression in viral myocarditis.Mol. Cell.
Biochem. 362, 141–148. doi: 10.1007/s11010-011-1136-3
Ye, X., Hemida, M. G., Qiu, Y., Hanson, P. J., Zhang, H. M., and Yang, D.
(2013). MiR-126 promotes coxsackievirus replication by mediating cross-talk
of ERK1/2 and Wnt/beta-catenin signal pathways. Cell. Mol. Life Sci. 70,
4631–4644. doi: 10.1007/s00018-013-1411-4
Yoshikawa, T., Ihira, M., Suzuki, K., Suga, S., Kito, H., Iwasaki, T., et al. (2001).
Fatal acute myocarditis in an infant with human herpesvirus 6 infection. J. Clin.
Pathol. 54, 792–795. doi: 10.1136/jcp.54.10.792
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Tse, Yeo, Chan, Lai and Yan. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 11 July 2016 | Volume 7 | Article 308
